The Platelet-Stimulating Effect of Adrenaline Through u2- Adrenerg ic Receptors Req u ires Si m u lta neous Activation by a True Stimulatory Platelet Agonist Evidence That Adrenaline Per Se Does Not Induce Human Platelet Activation ln Mtro

Summary The stimulating effect of adrenaline on human platelet phospholipase C (PLC) activation and responses in vitro (shape change , aggregation and dense granule secretion) was investigated with respect to its dependence on exogenously added agonists. All experiments were performed with human gel-filtered platelets pretreated with acetylsalicylic acid to prevent endogenous stimulation by the arachidonate pathway. (1) Preliminary experiments demonstrated the presence of trace amounts of extracellular ADP (0.05-0.58 pM) in non-stimulated platelet suspensions; ADP was effectively converted to ATP by the enzyme system creatine phosphate (CP)/creatine phosphokinase (CPK) . (2) The adrenaline-induced optical aggregation and single particle (platelet) disappearance in the presence of trace amounts of ADP were almost abolished by the ADP-scavanger system CPI CPK. (3) The response of CP/CPK-treated thrombin- or platelet-activating factor (PAF)-stimulated platelets was markedly increased by a subsequent addition of adrenaline. When hirudin or BN 50726 was added just prior to adrenaline to terminate the activation by thrombin or PAR respectively, the stimulating effect of adrenaline was also abolished. (4) CP/CPK-treated, PAF-stimulated platelets rapidly developed decreased responsiveness to a subsequent addition of PAE When adrenaline was added instead of a second addition of PAR the stimulating effect of adrenaline was gradually decreased and prevented in parallel with the homologous desensitization of PAE (5) The weak platelet agonist serotonin by itself induced only shape change in CP/CPK-treated platelets. Adrenaline failed to enhance the extent of this serotonin-induced platelet activation. (6) These results strongly suggest that adrenaline per se is not a platelet agonist in vitro but acts to enhance the stimulation induced by true agonists.

[1]  M. Kroll,et al.  Biochemical mechanisms of platelet activation. , 1989, Blood.

[2]  V. Steen,et al.  Potentiation by adrenaline of thrombin‐induced elevation of pHi is not essential for synergistic activation of human platelets , 1989, FEBS letters.

[3]  M. Scrutton,et al.  Epinephrine induces platelet fibrinogen receptor expression, fibrinogen binding, and aggregation in whole blood in the absence of other excitatory agonists. , 1989, Blood.

[4]  J. Cazenave,et al.  Epinephrine potentiates human platelet activation but is not an aggregating agent. , 1988, The American journal of physiology.

[5]  J. Mustard,et al.  Conditions Affecting the Responses of Human Platelets to Epinephrine , 1988, Thrombosis and Haemostasis.

[6]  V. Steen,et al.  Synergism between thrombin and adrenaline (epinephrine) in human platelets. Marked potentiation of inositol phospholipid metabolism. , 1988, The Biochemical journal.

[7]  E. Lapetina,et al.  The Na+/H+ antiporter is not involved in potentiation of thrombin-induced responses by epinephrine. , 1988, Biochemical and biophysical research communications.

[8]  O. Tysnes,et al.  Stimulation of phosphate uptake in human platelets by thrombin and collagen. Changes in specific 32P labeling of metabolic ATP and polyphosphoinositides. , 1987, The Journal of biological chemistry.

[9]  V. Steen,et al.  Current aspects on human platelet activation and responses , 1987, European journal of haematology.

[10]  L. Brass,et al.  Activation of phospholipases A and C in human platelets exposed to epinephrine: role of glycoproteins IIb/IIIa and dual role of epinephrine. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Colman,et al.  Platelet ADP receptor and alpha 2-adrenoreceptor interaction. Evidence for an ADP requirement for epinephrine-induced platelet activation and an influence of epinephrine on ADP binding. , 1986, The Journal of biological chemistry.

[12]  N. Thompson,et al.  Synergistic responses in human platelets. Comparison between aggregation, secretion and cytosolic Ca2+ concentration. , 1986, European journal of biochemistry.

[13]  H. Motulsky,et al.  Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase. , 1986, Molecular pharmacology.

[14]  V. Steen,et al.  Synergism between Thrombin and Epinephrine in Human Platelets: Different Dose-Response Relationships for Aggregation and Dense Granule Secretion , 1985, Thrombosis and Haemostasis.

[15]  M. Maguire,et al.  Alpha 2-adrenoceptor coupling to adenylate cyclase in adrenaline insensitive human platelets. , 1985, European journal of pharmacology.

[16]  F. Lanza,et al.  Studies of Alpha2-Adrenergic Receptors of Intact and Functional Washed Human Platelets by Binding of 3H-Dihydroergocryptine and 3H-Yohimbine-Correlation of 3H-Yohimbine Binding with the Potentiation by Adrenaline of ADP-Induced Aggregation , 1985, Thrombosis and Haemostasis.

[17]  A. Verhoeven,et al.  Quantification of energy consumption in platelets during thrombin-induced aggregation and secretion. Tight coupling between platelet responses and the increment in energy consumption. , 1984, The Biochemical journal.

[18]  P. Weber,et al.  Activation of phospholipase C is dissociated from arachidonate metabolism during platelet shape change induced by thrombin or platelet-activating factor. Epinephrine does not induce phospholipase C activation or platelet shape change. , 1984, The Journal of biological chemistry.

[19]  L. Limbird,et al.  The influence of Na+ on the alpha 2-adrenergic receptor system of human platelets. A method for removal of extraplatelet Na+. Effect of Na+ removal on aggregation, secretion, and cAMP accumulation. , 1983, The Journal of biological chemistry.

[20]  A. Herman,et al.  5-hydroxytryptamine and platelet aggregation. , 1983, Federation proceedings.

[21]  C. Dangelmaier,et al.  Thrombin and ionophore A23187-induced dense granule secretion in storage pool deficient platelets: evidence for impaired nucleotide storage as the primary dense granule defect. , 1983, Blood.

[22]  E. Peerschke.  Induction of human platelet fibrinogen receptors by epinephrine in the absence of released ADP. , 1982, Blood.

[23]  H. Weiss,et al.  Dependence of Human Platelet Functional Responses on Divalent Cations: Aggregation and Secretion in Heparin- and Hirudin-Anticoagulated Platelet-Rich Plasma and the Effects of Chelating Agents , 1981, Thrombosis and Haemostasis.

[24]  K. Jakobs,et al.  Epinephrine inhibits adenylate cyclase and stimulates a GTPase in human platelet membranes via alpha-adrenoceptors. , 1981, FEBS letters.

[25]  E. Plow,et al.  Induction of the fibrinogen receptor on human platelets by epinephrine and the combination of epinephrine and ADP. , 1980, The Journal of biological chemistry.

[26]  H. Motulsky,et al.  Characterization of alpha 2-adrenergic receptors on human platelets using [3H]yohimbine. , 1980, Biochemical and Biophysical Research Communications - BBRC.

[27]  T. Detwiler,et al.  Dissociation of thrombin from platelets by hirudin. Evidence for receptor processing. , 1979, The Journal of biological chemistry.

[28]  O. Tangen,et al.  Nucleotide leakage from platelets in artificial media: prevention by albumin and other macromolecules and relation to ADP-induced platelet aggregation. , 2009, Scandinavian journal of haematology.

[29]  G. Roberts,et al.  Effects of adrenaline on human blood platelets , 1967, The Journal of physiology.

[30]  G. Born,et al.  Effects of the Numbers and Sizes of Platelet Aggregates on the Optical Density of Plasma , 1967, Nature.

[31]  D. C. Macmillan.  Secondary Clumping Effect in Human Citrated Platelet-Rich Plasma Produced by Adenosine Diphosphate and Adrenaline , 1966, Nature.

[32]  J. R. O'brien.  A comparison of platelet aggregation produced by seven compounds and a comparison of their inhibitors , 1964, Journal of clinical pathology.

[33]  J. R. O'brien.  Some Effects of Adrenaline and Anti-Adrenaline Compounds on Platelets in vitro and in vivo , 1963, Nature.